Ascendant Diagnostics Receives ASTA Investment for Breast Cancer Detection

by Mark Carter  on Thursday, Jul. 25, 2013 12:11 pm  

Senior Scientist Anna Daily prepares a tear sample in Ascendant Diagnostics' Fayetteville lab.

Fayetteville biotech firm Ascendant Diagnostics has received a $300,000 investment from the Arkansas Science & Technology Authority for development of its MelodyDX product that uses tear samples to screen for breast cancer.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access stories older than 20 days.

Purchase Now

Already have archive access? Login to view this article.

Search

Latest Arkansas Business Poll

Should Congress renew the Export-Import Bank?